This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garraffo, R
Right arrow Articles by Lapalus, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garraffo, R
Right arrow Articles by Lapalus, P

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 November; 35(11): 2215-2218

In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils.

R Garraffo, D Jambou, R M Chichmanian, S Ravoire and P Lapalus

Department of Experimental and Clinical Pharmacology, Hospital-University of Nice, France.

ABSTRACT

Early in vitro investigations have shown that ciprofloxacin is concentrated within human neutrophils (polymorphonuclear leukocytes [PMNs]) at between 3 and 11 times the extracellular concentration. The elution of ciprofloxacin from cells is relatively rapid when the extracellular concentration is reduced. In order to estimate the in vivo intracellular penetration of ciprofloxacin and to determine its intracellular pharmacokinetics, PMNs were recovered from blood samples drawn from healthy volunteers at different times during a 24-h period after they were given a 750-mg oral dose. High-performance liquid chromatographic determination of ciprofloxacin in serum and cells showed that the intracellular/serum ratio was 3.7 at 1.5 h (maximum concentration of drug in serum), 5.7 at 12 h, and 20 at 24 h. The area under the curve ratio was 3.73. The mean elimination half-lives of ciprofloxacin were 3.7 and 6.2 h in serum and PMNs, respectively. These data show that in vivo findings are in agreement with in vitro findings. The large uptake of ciprofloxacin by PMNs combined with a prolonged intracellular half-life described under the conditions of human therapy should provide the basis for the use of ciprofloxacin in infections caused by susceptible intracellular bacteria.

Antimicrob Agents Chemother. 1991 November; 35(11): 2215-2218




This article has been cited by other articles:

  • Langer, O., Karch, R., Muller, U., Dobrozemsky, G., Abrahim, A., Zeitlinger, M., Lackner, E., Joukhadar, C., Dudczak, R., Kletter, K., Muller, M., Brunner, M. (2005). Combined PET and Microdialysis for In Vivo Assessment of Intracellular Drug Pharmacokinetics in Humans. JNM 46: 1835-1841 [Abstract] [Full Text]  
  • Brunner, M., Langer, O., Dobrozemsky, G., Muller, U., Zeitlinger, M., Mitterhauser, M., Wadsak, W., Dudczak, R., Kletter, K., Muller, M. (2004). [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans. Antimicrob. Agents Chemother. 48: 3850-3857 [Abstract] [Full Text]  
  • Walters, J. D., Nakkula, R. J. (2003). Ciprofloxacin Transport by Chemoattractant-Activated Polymorphonuclear Leukocytes: Regulation by Priming and Protein Kinase C. Antimicrob. Agents Chemother. 47: 3345-3348 [Abstract] [Full Text]  
  • Yang, Q., Nakkula, R.J., Walters, J.D. (2002). Accumulation of Ciprofloxacin and Minocycline by Cultured Human Gingival Fibroblasts. JDR 81: 836-840 [Abstract] [Full Text]  
  • Cacchillo, D. A., Walters, J. D. (2002). Effect of Ciprofloxacin on Killing of Actinobacillus actinomycetemcomitans by Polymorphonuclear Leukocytes. Antimicrob. Agents Chemother. 46: 1980-1984 [Abstract] [Full Text]  
  • Bounds, S. J., Nakkula, R., Walters, J. D. (2000). Fluoroquinolone Transport by Human Monocytes: Characterization and Comparison to Other Cells of Myeloid Lineage. Antimicrob. Agents Chemother. 44: 2609-2614 [Abstract] [Full Text]  
  • Smith, R. P., Baltch, A. L., Franke, M. A., Michelsen, P. B., Bopp, L. H. (2000). Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother 45: 483-488 [Abstract] [Full Text]  
  • Walters, J. D., Zhang, F., Nakkula, R. J. (1999). Mechanisms of Fluoroquinolone Transport by Human Neutrophils. Antimicrob. Agents Chemother. 43: 2710-2715 [Abstract] [Full Text]  
  • Vazifeh, D., Bryskier, A., Labro, M.-T. (1999). Mechanism Underlying Levofloxacin Uptake by Human Polymorphonuclear Neutrophils. Antimicrob. Agents Chemother. 43: 246-252 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»